Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones

被引:113
作者
Tsuda, H
Takarabe, T
Hasegawa, T
Murata, T
Hirohashi, S
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 104, Japan
[2] JA Suzuka Gen Hosp, Dept Pathol, Suzuka, Mie, Japan
[3] JA Suzuka Gen Hosp, Clin Labs, Suzuka, Mie, Japan
关键词
breast cancer; myoepithelial differentiation; central acellular zone;
D O I
10.1016/S0046-8177(99)90028-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We hypothesized that invasive ductal carcinomas (IDCs) with large central acellular zones comprising necrosis, tissue infarction, collagen, and hyaline material on their cut surfaces are formed in association with myoepithelial differentiation of the carcinoma cells. To verify this, the expression of S100 protein, alpha-smooth muscle actin (alpha-SMA), and glial fibrillary acidic protein (GFAP) and keratin 14, which has been shown to represent the myoepithelial immunophenotype, was examined immunohistochemically in 18 IDCs with such central zones covering more than 30% of each tumor area, 18 IDCs without such areas as negative controls, and 10 metaplastic carcinomas as positive controls for myoepithelial differentiation. Expression of S100, detected with a polyclonal antibody, S100-alpha, S100-beta, alpha-SMA, GFAP, and keratin 14, was observed in 61%, 83%, 39%, 33%, 28%, and 39% of the IDCs with large central acellular zones, 17%, 44%, 6%, 6%, 0%, and 6% of the IDCs without such zones, and 80%, 70%, 50%, 100%, 80%, and 50% of the metaplastic carcinomas, respectively. We concluded that IDCs with large central acellular zones frequently contain carcinomas showing myoepithelial differentiation. Such histological and immunohistochemical features in IDCs would be expected to be clinicopathologically significant. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:1134 / 1139
页数:6
相关论文
共 29 条
[1]  
Allen AC, 1940, ARCH PATHOL, V29, P589
[2]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[3]   S-100 PROTEIN POSITIVITY IN BREAST CARCINOMAS - A POTENTIAL PITFALL IN DIAGNOSTIC IMMUNOHISTOCHEMISTRY [J].
DWARAKANATH, S ;
LEE, AKC ;
DELELLIS, RA ;
SILVERMAN, ML ;
FRASCA, L ;
WOLFE, HJ .
HUMAN PATHOLOGY, 1987, 18 (11) :1144-1148
[4]  
Funahashi H, 1998, J SURG ONCOL, V68, P25, DOI 10.1002/(SICI)1096-9098(199805)68:1<25::AID-JSO6>3.0.CO
[5]  
2-N
[6]   S100-PROTEIN IN HUMAN MAMMARY TISSUE - IMMUNOREACTIVITY IN BREAST-CARCINOMA, INCLUDING PAGETS-DISEASE OF THE NIPPLE, AND VALUE AS A MARKER OF MYOEPITHELIAL CELLS [J].
GILLETT, CE ;
BOBROW, LG ;
MILLIS, RR .
JOURNAL OF PATHOLOGY, 1990, 160 (01) :19-24
[7]  
GOULD VE, 1990, AM J PATHOL, V137, P1143
[8]  
HAIMOTO H, 1987, LAB INVEST, V57, P489
[9]  
Hamperl H, 1970, Curr Top Pathol, V53, P161
[10]   Fibrotic focus in invasive ductal carcinoma of the breast: A histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation [J].
Hasebe, T ;
Tsuda, H ;
Tsubono, Y ;
Imoto, S ;
Mukai, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (06) :590-599